The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer/Experiment 2/Signature 2
From BugSigDB
Reviewed Marked as Reviewed by Folakunmi on 2024-4-9
Source: Fig. 3B, Supp. Table S7
Description: Differential abundance between responders and non-responders to Anti–PD-1/PD-L1 immunotherapy in patients with Colorectal Cancer (CRC)
Abundance in Group 1: decreased abundance in Responders (colorectal cancer - CRC)
| NCBI | Quality Control | Links |
|---|---|---|
| Bacteroides | ||
| Bifidobacterium | ||
| Lachnoclostridium | ||
| Odoribacter | ||
| Oscillibacter | ||
| Parabacteroides | ||
| Subdoligranulum | ||
| Coprococcus_2Coprococcus_2 |
Revision editor(s): Scholastica, WikiWorks
